

Biotheus, a biotech company focused on curing malignant tumors and autoimmune diseases, has secured an undisclosed amount of funding. General Atlantic and IDG Capital led the round.
Source: Press Release
Biotheus, a biotech company focused on curing malignant tumors and autoimmune diseases, has secured an undisclosed amount of funding.
Biotheus, a biotech company focused on curing malignant tumors and autoimmune diseases, has secured an undisclosed amount of funding. General Atlantic and IDG Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination